HIV-Risk Reduction Intervention for Juvenile Offenders on Probation: The PHAT Life Group Randomized Controlled Trial

in chicago •  7 years ago 

By a News Reporter-Staff News Editor at Physician Law Weekly -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According to news reporting out of Chicago, Illinois, by NewsRx editors, research stated, “Juvenile offenders report high rates of sexual risk taking, increasing the possibility of HIV. This 2-arm group randomized controlled trial tested the efficacy of PHAT Life, a sexual risk reduction program, compared with a time-matched health promotion program for youth on probation.”

Our news journalists obtained a quote from the research from the University of Illinois, “Male and female 13- to 17-year-olds (M = 16.08; SD = 1.09) recently arrested and placed on probation at an Evening Reporting Center were eligible for the study. Youth were 66% male, and 90% African American. Teens self-reported their sexual behavior (condom use, number of sexual partners) at baseline and 6 months. Retention was 85%. Youth were randomized to PHAT Life (n = 163) or a health promotion program (n = 147). Among youth reporting the highest risk at baseline (a composite measure of multiple partners and inconsistent condom use), those who received PHAT Life were over 4 times more likely than the control group to report a lower level of risk (i.e., no sex or one partner plus consistent condom use) by 6 months, OR = 4.28 with 95% CI [1.37, 13.38], SE = 0.58, p = .01. Among sexually active teens who reported sexual debut before 12-years-old, those who received PHAT Life reported significantly fewer sexual partners at 6-months than controls, partial eta squared = .32, p = .002. Findings support PHAT Life’s efficacy to reduce sexual risk for juvenile offenders on probation.”

According to the news editors, the research concluded: “Future research should examine how best to disseminate PHAT Life to ensure that it is self-sustaining within the juvenile justice system.”

For more information on this research see: HIV-Risk Reduction Intervention for Juvenile Offenders on Probation: The PHAT Life Group Randomized Controlled Trial. Health Psychology , 2018;37(4):364-374. Health Psychology can be contacted at: Amer Psychological Assoc, 750 First St NE, Washington, DC 20002-4242, USA.

Our news journalists report that additional information may be obtained by contacting G. Donenberg, University of Illinois, Center Disseminat & Implementat Sci, Hlth Youths Program, Community Outreach Intervent Projects, Chicago, IL 60612, United States. Additional authors for this research include E. Emerson and A.D. Kendall.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1037/hea0000582. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

CITATION: (2018-05-02), Recent Research from University of Illinois Highlight Findings in HIV/AIDS (HIV-Risk Reduction Intervention for Juvenile Offenders on Probation: The PHAT Life Group Randomized Controlled Trial), Physician Law Weekly, 95, ISSN: 1551-5303, BUTTER® ID: 015569476

From the newsletter Physician Law Weekly.
https://www.newsrx.com/Butter/#!Search:a=15569476


This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.

We have been in business for more than 20 years and our full contact information is available on our main corporate website.

We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.

NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.

View Newsletter Titles

About NewsRx® and Contact Information

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!